Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikanda Kunda

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The American Journal of Tropical Medicine and Hygiene|November 2, 2023
COVID-19 in Patients with Drug-Resistant Tuberculosis in LesothoAfom T Andom, Meseret Asfaw, Llang Bridget Maama-Maime, et al.
Emerging Infectious Diseases|December 11, 2025
Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, LesothoKwonjune J Seung, Meseret Asfaw, Mikanda Kunda, et al.
Global Health Action|February 2, 2024
Low body mass index as a predictor of sputum culture conversion and treatment outcomes among patients receiving treatment for multidrug-resistant tuberculosis in LesothoLawrence Oyewusi, Chengbo Zeng, K J Seung, et al.
The New England Journal of Medicine|January 29, 2025
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible TuberculosisLorenzo Guglielmetti, Uzma Khan, Gustavo E Velásquez, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The American Journal of Tropical Medicine and Hygiene|November 2, 2023
COVID-19 in Patients with Drug-Resistant Tuberculosis in LesothoAfom T Andom, Meseret Asfaw, Llang Bridget Maama-Maime, et al.
Emerging Infectious Diseases|December 11, 2025
Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, LesothoKwonjune J Seung, Meseret Asfaw, Mikanda Kunda, et al.
Global Health Action|February 2, 2024
Low body mass index as a predictor of sputum culture conversion and treatment outcomes among patients receiving treatment for multidrug-resistant tuberculosis in LesothoLawrence Oyewusi, Chengbo Zeng, K J Seung, et al.
The New England Journal of Medicine|January 29, 2025
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible TuberculosisLorenzo Guglielmetti, Uzma Khan, Gustavo E Velásquez, et al.
Pageof 1